iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) is an equity-based exchange-traded fund designed to provide investors with exposure to the U.S. biotechnology sector. The fund’s primary function is to track the performance of the NASDAQ Biotechnology Index, which includes a broad array of leading biotechnology and pharmaceutical companies listed on the NASDAQ. It holds over 250 individual stocks and is managed with a passive strategy, aiming to replicate the index’s composition and returns as closely as possible through physical replication. The ETF is structured as a UCITS fund and offers semi-annual income distributions, making it suitable for investors seeking periodic cash flows. With a total expense ratio of 0.35% per annum and assets under management around 42 million euros, it represents a specialized and targeted vehicle for accessing developments in biotechnology, including pharmaceutical innovation, genetic research, and healthcare solutions. By focusing investment solely on U.S.-listed biotechnology companies, this fund plays an integral role for market participants seeking diversified exposure to one of the most dynamic sectors in healthcare, enabling participation in the evolution of medical science and technology within the global financial market.